The Renasant Bio team (courtesy Renasant)

Kid­ney health biotech emerges with $54M to fol­low in Ver­tex’s foot­steps

A Berke­ley, CA-based biotech that wants to repli­cate Ver­tex’s suc­cess with cor­rec­tor and po­ten­tia­tor med­i­cines has raised a $54.5 mil­lion seed round.

The fund­ing, dis­closed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.